ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    smm2001
Previous Study | Return to List | Next Study

A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02316106
Recruitment Status : Active, not recruiting
First Posted : December 12, 2014
Last Update Posted : September 17, 2018
Sponsor:
Information provided by (Responsible Party):
Janssen Research & Development, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : July 17, 2020
  Estimated Study Completion Date : July 17, 2020